Stay current with product and data science updates, industry and technology trends, and culture updates from the CancerLinQ team.
Updated February 18, 2022: Demographics of Patients with Cancer and COVID-19 Disease
Patients with cancer and COVID-19 constitute those with a cancer diagnosis who fit at least one of the following three criteria:
EMPLOYEE SPOTLIGHT: Melissa Miller, MPH
Meet Melissa Miller, Associate Director of Clinical and Patient Products at CancerLinQ.
Make the Most of Your Data with CancerLinQ Professional Services
By Adam Blair, Manager Oncology Data Quality
As a practice leveraging CancerLinQ products, you’re able to use the SmartLinQ QCP Pathway to seamlessly and automatically track, monitor, and…
Updated August 26, 2021 - Demographics of Patients with Cancer and COVID-19 Disease
Forty-seven of the CancerLinQ practices providing regular data updates also provided testing information for and/or diagnostic reports of COVID-19…
Unlocking data. Discovering trends. Improving care.
Experience the latest from CancerLinQ Insights: Clinical Data Dashboards
EMPLOYEE SPOTLIGHT: Dr. Danielle Dell Potter
Meet Dr. Danielle Dell Potter, Principal Scientist and Head of Real World Evidence at CancerLinQ.
From One Patient to Millions: Making All the Right Connections
By Jack Aiello
How CancerLinQ uses real-world data to better inform the cancer patient journey
The Future of CancerLinQ - CEO Perspective
By Sean Khozin, MD, MPH
A patient-centered and equitable approach to transforming cancer care and research
Impact of COVID-19 Disease on Oncology Practice: Targeted Therapies Used in Lung Cancer
COVID-19 Surveillance Report
Trends in prescription and/or administration of targeted therapies used in lung cancer by month since January 2019